World Rare Disease & Orphan Therapeutic Market Analysis - How the Launch of New Pipeline Agents is Set to Change the Landscape by 2025

DUBLIN, Jan. 5, 2021 /PRNewswire/ -- The "Rare Disease & Orphan Therapeutic Market Analysis & Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo
Research and Markets Logo

This industry analysis report tackles the major orphan drugs within the rare disease therapeutics market and encompasses the most prevalent and dominant therapies in this space. The market value for the current major orphan therapeutic space is analysed and forecast to 2025 with corresponding CAGR percentages. Market details are provided by drug type, therapeutic area, geography and also specific sales and forecast of the major drugs in the field. Key industry players and developments are covered along with the growing pipeline and clinical trials. Regional insights and approval trends are given, as are the strengths, opportunities and challenges of this growing market.

The scope of the report provides an in-depth analysis of the therapeutics space by value and forecast to 2025 that is subdivided into:

  • Small molecules

  • Antibodies

  • Oligonucleotides

  • Gene therapy

  • Cell therapy

The report reviews the most dominant therapeutics in each sub-market and provides clinical evaluation, sales forecast and market share to 2025. It gives a comparison between the current market values of the main therapies and how the landscape will change by 2025 with the launch of new pipeline agents. This includes some of the main blockbusters such as

  • Revlimid

  • Trikafta

  • Darzalex

  • Spinraza

  • Hemlibra

  • Venclexta

  • Soliris

  • Adcetris

  • Jakafi

  • Lenvima

  • Lynparza

  • Ultomiris

  • Yescarta

  • Pomalyst

  • Vyndaqel

  • Ninlaro

  • Liso-cel

Therefore the reader is provided with data on the current main dominant therapeutics in the area and also the drugs that will dominate the space by 2025. This analysis is provided for each sub-therapeutic area. Geographical breakdown analysis is further provided and is segmented into North America, Europe, Asia Pacific and the Rest of the World.

The scope of the report also includes the orphan drug market by indication and disease type with specific detail given to oncology, hematological disorders, CNS, respiratory, immunomodulation, cardiovascular, musculoskeletal, anti-infectives, endocrine and gastrointestinal disease.

Key players and company profiles in the rare disease market are provided including:

  • Bristol Myers Squibb

  • Roche/Genentech

  • Alexion

  • Janssen J&J

  • Biogen

  • Novartis

  • AstraZeneca Merck

  • Eisai

  • Takeda

  • Abbvie Genentech

  • Gilead (Kite)

  • Pfizer

  • Vertex

  • Argenx

The report also includes a detailed description of the following trends and market shapers:

  • USA (FDA) and European (EMA) Orphan Drug Approvals

  • Venture Funding Increasing Over Time

  • Therapeutic Areas Dominating Approval

  • Orphan Drug Designation Trends

  • Repurposing Existing Therapeutics

  • Japan Approval Trends

  • South Korea Approval Trends

  • China Approval Trends

The growing rare disease pipeline and clinical trial environment is evaluated with specific consideration given to:

  • Small Molecules and Multiple Myeloma

  • Gene and Cell Therapy in Melanoma

  • Gene and Cell Therapy in ADA-SCID

  • Gene and Cell Therapy agents in Hemophilia A and B

  • CAR-T Therapy agents in Pancreatic Cancer

  • CAR-T Therapy agents in Multiple Myeloma

  • Gene and Cell Therapies in Duchenne Muscular Dystrophy

  • RPE65 Genetic Retinal Mutation

  • Rare Eye Disorders

  • Spinal Muscular Atrophy

  • Sickle Cell Anaemia

  • Cystic Fibrosis

  • Erythropoietic Protoporphyria

  • Guillain-Barre Syndrome

  • Scleroderma

  • Alpha-1 Antitrypsin Deficiency

  • Juvenile Idiopathic Arthritis

For more information about this report visit https://www.researchandmarkets.com/r/xjtq3e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/world-rare-disease--orphan-therapeutic-market-analysis---how-the-launch-of-new-pipeline-agents-is-set-to-change-the-landscape-by-2025-301201030.html

SOURCE Research and Markets

Latest Stories

  • Why did Trump pick fights with Congress he was sure to lose?

    President Trump stood little chance of compelling Congress to change the stimulus package or defense funding bill. So why did he take a stand on both pieces of legislation?

  • Wisconsin Gov. Activates National Guard ahead of Charging Decision in Kenosha Police Shooting

    Wisconsin governor Tony Evers mobilized the National Guard on Monday to provide support to law enforcement in Kenosha, ahead of an expected decision on whether to press charges a police shooting.A Kenosha officer shot Jacob Blake, an African American man, in August while responding to a domestic violence call. Authorities had issued an arrest warrant for Blake for suspected third-degree sexual assault. A white officer shot Blake several times during the attempted arrest, and Blake was left paralyzed from the waist down.Video of Blake's shooting quickly went viral and was followed by a week of riots in Kenosha, during which rioters destroyed dozens of businesses in the city. The riots came in the wake of widespread civil unrest after the police killing of George Floyd, an African American resident of Minneapolis.The Kenosha County District Attorney's Office is expected to announce a decision on whether to charge the officer who shot Blake sometime within last two weeks of January. Governor Evers ordered the National Guard to provide 500 service members to assist Kenosha law enforcement ahead of the district attorney's decision."We are continuing to work with our local partners in the Kenosha area to ensure they have the state support they need, just as we have in the past,” Evers told reporters on Monday. “Our members of the National Guard will be on hand to support local first responders, ensure Kenoshans are able to assemble safely, and to protect critical infrastructure as necessary.”Kenosha mayor John Antaramian and police chief Daniel Miskinis said in a joint statement that the city was preparing for possible unrest."Mayor Antaramian has been informed that the decision is likely to be announced within the first two weeks of January and is working with Chief Miskinis and other partners to protect peaceful demonstration and to guard against unlawful activity," the two said. "Our responsibility to public safety is paramount, and we are preparing for a number of possible public demonstration and safety efforts."

  • Ex-chairman of China Huarong Asset Management sentenced to death

    BEIJING (Reuters) -The former chairman of China Huarong Asset Management Co has been sentenced to death, a court in the northern city of Tianjin said on Tuesday, in one of the country's highest profile corruption cases. Lai Xiaomin was convicted of receiving or seeking bribes totalling 1.788 billion yuan ($276.72 million) from 2008 to 2018, when he was also a senior banking regulator, according to the Secondary Intermediate People's Court of Tianjin. Lai, who was expelled from the ruling Communist Party in 2018, was also convicted on a charge of bigamy.

  • GOP congressmembers won't reject Electoral College vote because party 'depends' on it for presidential wins

    Republican House members against an attempt to oppose the certification of the Electoral College's vote are saying the quiet part of their argument very, very loud.A coalition of 11 GOP senators are planning to join with some House Republicans to oppose the certification of President-elect Joe Biden's win on Wednesday, giving debunked claims of election fraud as their reasoning. But another group of seven House congressmembers warned against undermining trust in the Electoral College, saying in a Monday statement that doing so could cost the party its only chance to win a future presidential election.Reps. Thomas Massie (R-Ky.), Kelly Armstrong (R-N.D.), Ken Buck (R-Colo.), Mike Gallagher (R-Wisc.) Nancy Mace (R-S.C.), Tom McClintock (R-Calif.), and Chip Roy (R-Texas) released their joint statement Monday, claiming they do believe "significant abuses in our election system" took place in 2020. The U.S. electoral system should guarantee "only legal votes are cast to select its leaders" and the electors who formally choose them, the statement said. "But only the states have authority to appoint electors," and after they do so, Congress can only count their votes, the group wrote. "To take action otherwise" only "strengthen[s] the efforts of those on the left" who want to end the Electoral College altogether.From there, the groups gets specific about the "purely partisan" side of their argument. Republican presidential candidates have only won the popular vote once in the past 32 years, relying on the Electoral College for the majority of their wins. "If we perpetuate the notion that Congress may disregard certified electoral votes ... we will be delegitimizing the very system that led Donald Trump to victory in 2016, and that could provide the only path to victory in 2024," the congressmembers finished.Top intelligence officials and former Attorney General William Barr have affirmed there is no evidence of election-altering fraud in the 2020 election.More stories from theweek.com Are we witnessing the fall of the United States? After getting vaccinated, New Orleans woman delivers a blunt message to non-believers McConnell stares down the barrel of Trump's gun

  • White House denies Trump planning Scotland trip after Sturgeon tells him he’s not allowed to visit because of Covid

    Country’s first minister warned that playing golf was not ‘essential purpose’ in lockdown

  • Wisconsin city braces for protest as charging decision looms

    A southeastern Wisconsin city braced for another round of protests as prosecutors prepared to announce whether they'll charge a white police officer who shot a Black man in the back, leaving him paralyzed. Kenosha Police Officer Rusten Sheskey shot Jacob Blake seven times on Aug. 23 as Blake was about to get into an SUV during a domestic dispute. The police union has maintained Blake resisted arrest and was armed with a knife, although state investigators have said only that a knife was found on the floor of the vehicle.

  • Venezuela's Socialist Party seats congress following boycotted election

    Venezuela's Socialist Party on Tuesday inaugurated a congress controlled by allies of President Nicolas Maduro, a change that many Western nations have assailed as the product of a fraudulent election. The country's opposition, led by Juan Guaido, who has served as speaker of parliament since 2019, separately seated a committee of legislators in a virtual session, intended to rival the socialist-held National Assembly after the opposition boycotted legislative elections held on Dec. 6. The shift marks a formal consolidation of power for Maduro, who in early 2019 looked vulnerable as the United States and dozens of other countries recognized Guaido as Venezuela's rightful leader.

  • After getting vaccinated, New Orleans woman delivers a blunt message to non-believers

    Maureen Weil received the coronavirus vaccine Monday in New Orleans, and the 79-year-old hopes all of her fellow Americans follow in her footsteps.In an interview with NBC News, Weil said she felt "excited" and "blessed" to be among the first people to get the vaccine. "I have a chance to see a few more days on this Earth because I'm protected," Weil said. "I believe in science."When asked what she would tell people who question the vaccine and don't want to receive it, Weil responded, "I call them stupid because -- that or either a buffoon. Because that's the only thing I could think of that could justify their stupidity."She said a lot of people don't believe in the severity of the coronavirus pandemic, which has killed more than 350,000 Americans, because "they listen to the man that's in Washington, D.C., that's on his way out the door talking about how it's all a hoax and all that bullcorn. And he shouldn't be doing that because that's peoples' lives. Look at the parents who've died and left young children. I mean, it's sad."Getting the vaccine "didn't hurt," Weil said, and now she has "peace of mind," and "knows one thing for sure. I'm gonna save somebody else's life by protecting myself. I won't get the corona so I can't spread it to anybody else. So that gives me a little satisfaction that I'm doing it not just for myself but for others." Americans "have to believe in science," Weil said. "There's no other way. When we didn't have a vaccine we were really up the creek, weren't we? And we had a hole in the boat. But we got a vaccine, so we got safety." > "I know one thing for sure. I'm gonna save somebody else's life by protecting myself.> > ... > Because then I won't get the corona so I can't spread it to anybody else." > -Maureen Weil, coronavirus vaccine recipient pic.twitter.com/TSecX57iAu> > -- Maddow Blog (@MaddowBlog) January 5, 2021More stories from theweek.com Are we witnessing the fall of the United States? McConnell stares down the barrel of Trump's gun Have Democrats stumbled onto a recipe for winning in the South?

  • Iran issues Interpol arrest warrant for Trump over Soleimani killing as tensions rise

    Interpol rejected previous warrant issued for Mr Trump and other officials in June

  • Study: Warming already baked in will blow past climate goals

    The amount of baked-in global warming, from carbon pollution already in the air, is enough to blow past international agreed upon goals to limit climate change, a new study finds. For decades, scientists have talked about so-called “committed warming” or the increase in future temperature based on past carbon dioxide emissions that stay in the atmosphere for well over a century. Previous estimates, including those accepted by international science panels, were about a degree Celsius (1.8 degrees Fahrenheit) less than that amount of committed warming.

  • Trump's official schedule says he will 'make many calls and have many meetings' Monday

    With just over two weeks left in President Trump's presidency, the White House is still putting out his daily schedule, but the schedules keep "sounding weirder and weirder," CNN's Kevin Liptak observed Sunday night. He was specifically pointing to the guidance for how Trump will spend Monday, before he heads to Georgia to campaign for the Republican incumbents in twin Senate special elections on Tuesday. "President Trump will work from early in the morning until late in the evening," the White House said late Sunday. "He will make many calls and have many meetings."> This is a new addition to the President's daily schedule> > "President Trump will work from early in the morning until late in the evening. He will make many calls and have many meetings. " pic.twitter.com/mv2XihwKIN> > -- Ben Jacobs (@Bencjacobs) January 4, 2021There's a clear didn't-read-the-book-report vibe to Trump's official schedule, but we also know, thanks to Georgia's secretary of state and Trump's Twitter feed, that what Trump is working on and calling people about these days is his doomed effort to overturn his loss in the Nov. 3 election. The man who defeated him, President-elect Joe Biden, is also traveling to Georgia to campaign, his office said Sunday. Biden may have meetings and phone calls planned for Monday as well, but that didn't make his schedule. > Here's Biden's schedule guidance for tomorrow. pic.twitter.com/ldJ7SJznyP> > -- Daniel Dale (@ddale8) January 4, 2021More stories from theweek.com After getting vaccinated, New Orleans woman delivers a blunt message to non-believers McConnell stares down the barrel of Trump's gun Colbert's Late Show turns Trump's Georgia election call into a Stevie Wonder hit

  • Debbie Wasserman Schultz files censure resolution against Texas Republican

    South Florida Democratic Rep. Debbie Wasserman Schultz filed a censure resolution against Texas Republican Rep. Louie Gohmert on Tuesday after Gohmert said in a TV interview that “you’ve got to go to the streets” when a judge dismissed his lawsuit seeking to overturn the results of the 2020 election.

  • Biden: If Dems win in Georgia, '$2,000 checks will go out the door'

    President-elect delivers remarks at an Atlanta drive-in rally for Democratic Senate candidates

  • Black California surgeon 'walks the walk' on virus vaccine

    Dr. David Tom Cooke says his choice to participate in a clinical trial for a coronavirus vaccine is like his grandmother’s decision to leave the Jim Crow South to work in California’s naval shipyards during World War II. She was determined to contribute even though the country didn't recognize her as worthy of full rights. Today, it's Cooke's sense of duty and experience as a Black man that led him to test out Pfizer's vaccine in August and make it his mission to allay concerns about its safety among Black friends, family and community members. “When you look at the scourge of the COVID-19 pandemic, communities of color are disproportionately affected in regards to death," said Cooke, head of general thoracic surgery at UC Davis Health, the Sacramento area's major trauma center.

  • 11 Storage Beds to Keep You Organized in 2021

    Read on for space-saving, clutter-clearing magicOriginally Appeared on Architectural Digest

  • Trump news – live: Iran issues arrest warrant for president as he attacks Georgia runoff count

    Follow the latest updates

  • He was stopped for not using turn signals. Police said he was dealing cocaine

    A Miami cocaine dealer was jailed Monday morning after bringing more than six ounces of the drug into the Florida Keys, police said.

  • Germany heading towards extension of hard lockdown

    The German government and the country's 16 federal states have agreed to extend a strict lockdown until Jan. 31 in an effort to bring coronavirus infections under control, Bild newspaper reported on Monday, without providing a source. Chancellor Angela Merkel and the state premiers are scheduled on Tuesday to discuss a possible extension of the lockdown beyond Jan. 10. Germany was more successful than many European countries in keeping the coronavirus in check during the first wave in the spring but has seen a surge in new infections since the autumn.

  • Here we go again: What to expect as Georgia counts votes

    With control of the U.S. Senate at stake, all eyes are on a runoff election that has Republicans David Perdue and Kelly Loeffler facing Democrats Jon Ossoff and Raphael Warnock. Perdue got about 88,000 more votes than Ossoff in the general election, but a Libertarian candidate’s 115,000 votes kept him from topping 50%, which is required to win. Gov. Brian Kemp appointed Loeffler to the Senate in December 2019 after Sen. Johnny Isakson stepped down.

  • Airspace around one of busiest US airports closed after air traffic controller tests positive for Covid

    Flights were also delayed in Florida following positive coronavirus test